These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38741435)

  • 1. Safety of GMP-compliant iPSC lines generated by Sendai virus transduction is dependent upon clone identity and sex of the donor.
    Kuczynska Z; Neglur PK; Metin E; Liput M; Zychowicz M; Zayat V; Krześniak NE; Buzanska L; Kot M
    Folia Neuropathol; 2024; 62(1):32-46. PubMed ID: 38741435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cell line NIMHi010-A from dermal fibroblast cells of a healthy individual.
    Dash SS; Arunachal G; Nimonkar MM; Vengalil S; Nashi S; Chetan GK; Boddu VK; Nalini A; Markandeya YS
    Stem Cell Res; 2024 Apr; 76():103355. PubMed ID: 38412659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cell line (VRISGi004-A) from a healthy female donor by reprogramming erythroid progenitor cells.
    Luong TH; Pham TA; Nhung Nguyen TH; Nguyen XH
    Stem Cell Res; 2024 Apr; 76():103331. PubMed ID: 38341988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521.
    Skorik C; Mullin NK; Shi M; Zhang Y; Hunter P; Tang Y; Hilton B; Schlaeger TM
    Curr Protoc Stem Cell Biol; 2020 Mar; 52(1):e103. PubMed ID: 31977148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an erythroid progenitor-derived iPSC line, VRISGi002-A, from a healthy 27-year-old Vietnamese donor under a feeder-free system.
    Nhung Nguyen TH; Trinh Tran TT; Luong TH; Nguyen XH
    Stem Cell Res; 2022 Jul; 62():102824. PubMed ID: 35679757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines.
    Toivonen S; Ojala M; Hyysalo A; Ilmarinen T; Rajala K; Pekkanen-Mattila M; Äänismaa R; Lundin K; Palgi J; Weltner J; Trokovic R; Silvennoinen O; Skottman H; Narkilahti S; Aalto-Setälä K; Otonkoski T
    Stem Cells Transl Med; 2013 Feb; 2(2):83-93. PubMed ID: 23341440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
    Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
    Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Protocol for Culture and Characterization of Human Induced Pluripotent Stem Cells After Induction.
    Cheng YS; Xu M; Chen G; Beers J; Chen CZ; Liu C; Zou J; Zheng W
    Curr Protoc; 2023 Aug; 3(8):e866. PubMed ID: 37610273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of two lymphoblastoid-derived induced pluripotent stem cell (iPSC) lines from patients with phenylketonuria.
    Veleva D; Ay M; Ovchinnikov DA; Prowse ABJ; Menezes MJ; Nafisinia M
    Stem Cell Res; 2024 Jun; 77():103407. PubMed ID: 38552357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming human dermal fibroblast into induced pluripotent stem cells using nonintegrative Sendai virus for transduction.
    Tai L; Teoh HK; Cheong SK
    Malays J Pathol; 2018 Dec; 40(3):325-329. PubMed ID: 30580364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased reprogramming of human fetal hepatocytes compared with adult hepatocytes in feeder-free conditions.
    Hansel MC; Gramignoli R; Blake W; Davila J; Skvorak K; Dorko K; Tahan V; Lee BR; Tafaleng E; Guzman-Lepe J; Soto-Gutierrez A; Fox IJ; Strom SC
    Cell Transplant; 2014 Jan; 23(1):27-38. PubMed ID: 23394081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Good Manufacturing Practice-compliant human induced pluripotent stem cells: from bench to putative clinical products.
    Novoa JJ; Westra IM; Steeneveld E; Fonseca Neves N; Arendzen CH; Rajaei B; Grundeken E; Yildiz M; van der Valk W; Salvador A; Carlotti F; Dijkers PF; Locher H; van den Berg CW; Raymond KI; Kirkeby A; Mummery CL; Rabelink TJ; Freund C; Meij P; Wieles B
    Cytotherapy; 2024 Jun; 26(6):556-566. PubMed ID: 38483359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a Vietnamese ethnicity induced pluripotent stem cell line (VRISGi001-A) from umbilical cord blood hematopoietic stem cells under a feeder-free system.
    Tran TT; Nguyen TH; Nguyen TT; Nguyen XH
    Stem Cell Res; 2021 May; 53():102345. PubMed ID: 33878709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of pluripotent stem cells from autopsy donor-derived somatic cells.
    Hjelm BE; Rosenberg JB; Szelinger S; Sue LI; Beach TG; Huentelman MJ; Craig DW
    Neurosci Lett; 2011 Sep; 502(3):219-24. PubMed ID: 21839145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of human induced pluripotent stem cell lines from human dermal fibroblasts using a non-integration system.
    Uhm KO; Kim SJ; Jo EH; Go GY; Choi HY; Im YS; Ha HY; Kim JH; Koo SK
    Stem Cell Res; 2017 May; 21():13-15. PubMed ID: 28677527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of induced pluripotent stem cell line (RCMGi009-A) from urine cells of patient with fibrodysplasia ossificans progressiva.
    Kondrateva E; Grigorieva O; Kurshakova E; Panchuk I; Pozhitnova V; Voronina E; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2023 Aug; 70():103133. PubMed ID: 37307755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation.
    Li YP; Liu H; Jin ZB
    Stem Cell Res; 2020 Dec; 49():102075. PubMed ID: 33207307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming of a human induced pluripotent stem cell line from one 48-year-old healthy male donor.
    Guo R; Mu W; Liu X; Zhang J; Liu B; Du X; He J; Ma J; Cui H
    Stem Cell Res; 2021 May; 53():102339. PubMed ID: 33892291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
    Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
    PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.